The Canadian Rheumatology Association (CRA) has developed new treatment recommendations for RA that take into consideration Canada’s current healthcare environment.  These recommendations were created as a tool to help support clinical decision-making for healthcare providers and RA patients by a national working group of rheumatologists, researchers, family physicians and RA patient experts. Included are five overarching care principles and 26 treatment recommendations. These address general RA treatment strategies as well as specific treatment strategies for the use of glucocorticoids and traditional and biologic disease-modifying anti-rheumatic drugs (DMARDS).

Recommendations focusing on safety aspects of these therapies have also been developed and will be released following ratification, before the end of the year.

The treatment recommendations are available online through the Journal of Rheumatology and are also posted with supporting material on the CRA website.

Questions about the new guidelines?  Please email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it